Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases: held in Athens, 1 - 4 November 1990
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Oxford u.a.
Blackwell Scientific Publ.
1991
|
| Schriftenreihe: | British journal of haematology / Supplement
79,1 |
| Schlagworte: | |
| Beschreibung: | Literaturangaben |
| Beschreibung: | IV, 104 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV004576947 | ||
| 003 | DE-604 | ||
| 005 | 19911030 | ||
| 007 | t | ||
| 008 | 911029s1991 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)25031860 | ||
| 035 | |a (DE-599)BVBBV004576947 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-12 | ||
| 111 | 2 | |a International Symposium on Interferon Alpha Therapy in Malignant Diseases |d 1990 |c Athen |j Verfasser |0 (DE-588)3009428-8 |4 aut | |
| 245 | 1 | 0 | |a Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases |b held in Athens, 1 - 4 November 1990 |c ed. by: M. Aguet ... |
| 246 | 1 | 3 | |a Interferon-alpha therapy in malignant diseases |
| 264 | 1 | |a Oxford u.a. |b Blackwell Scientific Publ. |c 1991 | |
| 300 | |a IV, 104 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a British journal of haematology / Supplement |v 79,1 | |
| 500 | |a Literaturangaben | ||
| 650 | 4 | |a Interferon-alpha |x therapeutic use |v Congresses | |
| 650 | 4 | |a Neoplasms |x drug therapy |v Congresses | |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Interferon |g alpha- |0 (DE-588)4205303-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1991 |z Athen |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Interferon |g alpha- |0 (DE-588)4205303-1 |D s |
| 689 | 0 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Interferon |g alpha- |0 (DE-588)4205303-1 |D s |
| 689 | 1 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 1 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Aguet, Michel |e Sonstige |4 oth | |
| 810 | 2 | |a Supplement |t British journal of haematology |v 79,1 |w (DE-604)BV004440374 |9 79,1 | |
| 940 | 1 | |n oe | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-002815775 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 942 | 1 | 1 | |e 22/bsb |g 495 |
Datensatz im Suchindex
| _version_ | 1804118705842421761 |
|---|---|
| any_adam_object | |
| author_corporate | International Symposium on Interferon Alpha Therapy in Malignant Diseases Athen |
| author_corporate_role | aut |
| author_facet | International Symposium on Interferon Alpha Therapy in Malignant Diseases Athen |
| author_sort | International Symposium on Interferon Alpha Therapy in Malignant Diseases Athen |
| building | Verbundindex |
| bvnumber | BV004576947 |
| ctrlnum | (OCoLC)25031860 (DE-599)BVBBV004576947 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02087nam a2200505 cb4500</leader><controlfield tag="001">BV004576947</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19911030 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">911029s1991 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)25031860</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004576947</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">International Symposium on Interferon Alpha Therapy in Malignant Diseases</subfield><subfield code="d">1990</subfield><subfield code="c">Athen</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)3009428-8</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases</subfield><subfield code="b">held in Athens, 1 - 4 November 1990</subfield><subfield code="c">ed. by: M. Aguet ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Interferon-alpha therapy in malignant diseases</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford u.a.</subfield><subfield code="b">Blackwell Scientific Publ.</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IV, 104 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">British journal of haematology / Supplement</subfield><subfield code="v">79,1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interferon-alpha</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Interferon</subfield><subfield code="g">alpha-</subfield><subfield code="0">(DE-588)4205303-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1991</subfield><subfield code="z">Athen</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Interferon</subfield><subfield code="g">alpha-</subfield><subfield code="0">(DE-588)4205303-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Interferon</subfield><subfield code="g">alpha-</subfield><subfield code="0">(DE-588)4205303-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aguet, Michel</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t">British journal of haematology</subfield><subfield code="v">79,1</subfield><subfield code="w">(DE-604)BV004440374</subfield><subfield code="9">79,1</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="n">oe</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002815775</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="942" ind1="1" ind2="1"><subfield code="e">22/bsb</subfield><subfield code="g">495</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1991 Athen gnd-content |
| genre_facet | Konferenzschrift 1991 Athen |
| id | DE-604.BV004576947 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:14:33Z |
| institution | BVB |
| institution_GND | (DE-588)3009428-8 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002815775 |
| oclc_num | 25031860 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-12 |
| physical | IV, 104 S. Ill., graph. Darst. |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Blackwell Scientific Publ. |
| record_format | marc |
| series2 | British journal of haematology / Supplement |
| spelling | International Symposium on Interferon Alpha Therapy in Malignant Diseases 1990 Athen Verfasser (DE-588)3009428-8 aut Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 ed. by: M. Aguet ... Interferon-alpha therapy in malignant diseases Oxford u.a. Blackwell Scientific Publ. 1991 IV, 104 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier British journal of haematology / Supplement 79,1 Literaturangaben Interferon-alpha therapeutic use Congresses Neoplasms drug therapy Congresses Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Interferon alpha- (DE-588)4205303-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1991 Athen gnd-content Krebs Medizin (DE-588)4073781-0 s Interferon alpha- (DE-588)4205303-1 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Therapie (DE-588)4059798-2 s 1\p DE-604 Aguet, Michel Sonstige oth Supplement British journal of haematology 79,1 (DE-604)BV004440374 79,1 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 Interferon-alpha therapeutic use Congresses Neoplasms drug therapy Congresses Krebs Medizin (DE-588)4073781-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Therapie (DE-588)4059798-2 gnd Interferon alpha- (DE-588)4205303-1 gnd |
| subject_GND | (DE-588)4073781-0 (DE-588)4076066-2 (DE-588)4059798-2 (DE-588)4205303-1 (DE-588)1071861417 |
| title | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 |
| title_alt | Interferon-alpha therapy in malignant diseases |
| title_auth | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 |
| title_exact_search | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 |
| title_full | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 ed. by: M. Aguet ... |
| title_fullStr | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 ed. by: M. Aguet ... |
| title_full_unstemmed | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases held in Athens, 1 - 4 November 1990 ed. by: M. Aguet ... |
| title_short | Proceedings from an International Symposium on Interferon Alpha Therapy in Malignant Diseases |
| title_sort | proceedings from an international symposium on interferon alpha therapy in malignant diseases held in athens 1 4 november 1990 |
| title_sub | held in Athens, 1 - 4 November 1990 |
| topic | Interferon-alpha therapeutic use Congresses Neoplasms drug therapy Congresses Krebs Medizin (DE-588)4073781-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Therapie (DE-588)4059798-2 gnd Interferon alpha- (DE-588)4205303-1 gnd |
| topic_facet | Interferon-alpha therapeutic use Congresses Neoplasms drug therapy Congresses Krebs Medizin Pharmakotherapie Therapie Interferon alpha- Konferenzschrift 1991 Athen |
| volume_link | (DE-604)BV004440374 |
| work_keys_str_mv | AT internationalsymposiumoninterferonalphatherapyinmalignantdiseasesathen proceedingsfromaninternationalsymposiumoninterferonalphatherapyinmalignantdiseasesheldinathens14november1990 AT aguetmichel proceedingsfromaninternationalsymposiumoninterferonalphatherapyinmalignantdiseasesheldinathens14november1990 AT internationalsymposiumoninterferonalphatherapyinmalignantdiseasesathen interferonalphatherapyinmalignantdiseases AT aguetmichel interferonalphatherapyinmalignantdiseases |